- Home
- VTRS vs SWK Comparison
VTRS vs SWK Comparison
Compare VTRS & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- SWK
- Stock Information
- Founded
- VTRS 1961
- SWK 1843
- Country
- VTRS United States
- SWK United States
- Employees
- VTRS N/A
- SWK N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- SWK Industrial Machinery/Components
- Sector
- VTRS Health Care
- SWK Consumer Discretionary
- Exchange
- VTRS Nasdaq
- SWK Nasdaq
- Market Cap
- VTRS 12.9B
- SWK 15.9B
- IPO Year
- VTRS N/A
- SWK N/A
- Fundamental
- Price
- VTRS $11.71
- SWK $105.15
- Analyst Decision
- VTRS Hold
- SWK Hold
- Analyst Count
- VTRS 3
- SWK 8
- Target Price
- VTRS $12.33
- SWK $101.63
- AVG Volume (30 Days)
- VTRS 8.9M
- SWK 1.0M
- Earning Date
- VTRS 11-07-2024
- SWK 10-29-2024
- Dividend Yield
- VTRS 4.11%
- SWK 3.12%
- EPS Growth
- VTRS N/A
- SWK N/A
- EPS
- VTRS N/A
- SWK N/A
- Revenue
- VTRS $15,239,200,000.00
- SWK $15,584,300,000.00
- Revenue This Year
- VTRS N/A
- SWK N/A
- Revenue Next Year
- VTRS N/A
- SWK $3.04
- P/E Ratio
- VTRS N/A
- SWK N/A
- Revenue Growth
- VTRS N/A
- SWK N/A
- 52 Week Low
- VTRS $8.74
- SWK $76.57
- 52 Week High
- VTRS $13.62
- SWK $110.88
- Technical
- Relative Strength Index (RSI)
- VTRS 54.75
- SWK 48.59
- Support Level
- VTRS $11.28
- SWK $105.56
- Resistance Level
- VTRS $11.93
- SWK $109.91
- Average True Range (ATR)
- VTRS 0.21
- SWK 2.19
- MACD
- VTRS 0.04
- SWK -0.60
- Stochastic Oscillator
- VTRS 68.12
- SWK 9.88
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.